Frankfurt/Main, 02.07.2024 – Progyny, Inc., a leading US-based, Nasdaq listed company specializing in women’s health, fertility, and family building benefits, has acquired all shares of Apryl GmbH. Apryl GmbH is a Berlin-based fertility benefits provider founded in 2019 that offers companies a consulting and mediation platform in the areas of family planning, fertility, and reproductive health for their employees in a B2B context. With this acquisition, Progyny aims to enhance its operations in the global market. The parties involved have agreed to keep the transaction details confidential.
A CMS team led by Dr Heike Wagner advised Progyny on all legal aspects in connection with this transaction.
Press Contact
presse@cms-hs.com
